Skin Cancer Breakthrough? Genentech, Inc. and Curis, Inc. Experimental Drug GDC-0449 Shrinks Advanced Skin Cancer
ScienceDaily (Apr. 15, 2008) — A novel molecule, GDC-0449, shrinks tumors for patients with advanced basal cell carcinoma with limited side effects, suggesting a viable new treatment option for patients with the advanced form of this cancer, according to research presented at the 2008 Annual Meeting of the American Association for Cancer Research.